Onkologie. 2011:5(1):9-15

Breast cancer screening in the Czech Republic: results from mammographic screening centers 2003-2209

Miroslava Skovajsová
Mamma centrum MEDICON, Praha

In the Czech Republic breast cancer screening program has been functional since 2003. Till the end of 2009 2 518 710 asymptomatic women

have been mammographically examined. In this screening program 12,063 breast cancers have been detected with 70 % of them

in early T1 and Tis stages. This study explains quality control criteria applied and regularly checked in 66 screening centers and suggests

new options for increase of participation of women in the screening above current 50 % as well as other supportive ways to stabilize the

program, which is aimed on reduction of breast cancer mortality.

Keywords: mammographic screening, breast cancer, early detection

Published: February 25, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Skovajsová M. Breast cancer screening in the Czech Republic: results from mammographic screening centers 2003-2209. Onkologie. 2011;5(1):9-15.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Chiu SY, Duffy S, Yen AM, Tabár L, Smith RA, Chen HH. Effect of baseline breast density on breast cancer incidence, stage, mortality, and screening parameters: 25-year followup of a Swedish mammographic screening. Cancer Epidemiol Biomarkers Prev. 2010; 19(5): 1219-1228. Go to original source... Go to PubMed...
    2. Corsetti V, Houssami N, Ghirardi M, et al. Evidence of the effect of adjunct ultrasound screening in women with mammography-negative dense breasts: Interval breast cancers at 1year follow-up. Eur J Cancer. 2011; 4. [Epub ahead of print]. Go to original source... Go to PubMed...
    3. Duffy SW, Tabar L, Chen TH, Yen AM, Dean PB, Smith RA. What information should be given to women invited for mammographic screening for breast cancer? Womens Health (Lond Engl). 2006; 2(6): 829-833. Go to original source... Go to PubMed...
    4. Ghosh I, Sharma A. Mammographic screening for breast cancer: when and how frequent? Natl Med J India. 2010; 23(3): 152-153. Go to PubMed...
    5. Hellquist BN, Duffy SW, Abdsaleh S, Björneld L, Bordás P, Tabár L, Viták B, Zackrisson S, Nyström L, Jonsson H : Effectiveness of population-based service screening with mammography for women ages 40 to 49 years: evaluation of the Swedish Mammography Screening in Young Women (SCRY) cohort. Cancer. 2010; 29. [Epub ahead of print]. Go to original source... Go to PubMed...
    6. Inukai S, Ninomiya K. Cognitive factors relating to mammographic breast cancer screening. Nippon Koshu Eisei Zasshi. 2010; 57(9): 796-806. Go to PubMed...
    7. Paap E, Verbeek AL, Puliti D, Paci E, Broeders MJ. Breast cancer screening case-control study design: impact on breast cancer mortality. Ann Oncol. 2010; 5. [Epub ahead of print]. Go to original source... Go to PubMed...
    8. Sawaya GF, Gregory KD. The new mammographic screening guidelines: what were they thinking? Obstet Gynecol. 2010; 116(5): 1216; author reply 1216-1217. Go to original source... Go to PubMed...
    9. Skovajsová M. Mamodiagnostika - Integrovaný přístup. Praha: Galén 2003.
    10. Skovajsová M. Jednotka integrované mamární diagnostiky jako základ sítě akreditovaných pracovišť pro mamární screening - první zkušenosti podle nových pravidel preventivního programu. Klinická onkologie 2002; 15: 115-197.
    11. Skovajsová M, Hrnčířová I, Mutina Z. Pilotní projekty s názvem, ,Jednotka integrované mamární diagnostiky jako základ sítě pro mamární screening" - další zkušenosti podle nových pravidel preventivního programu. Čes. Radiol 2004; 58: 203-209.
    12. Skovajsová M, Bitmanová H. Screening nádorů prsu v některých zemích Evropy, srovnání se současným stavem v České republice. Čes. Radiol. 2004; 58: 268-269.
    13. Skovajsová M, Bartoňková H, Daneš J. Screening nádorů prsu v České republice. Klinická onkologie 2004; 17: 46-48.
    14. Skovajsová M. Preventivní vyšetřování prsů - první zkušenosti s mammárním screeningem. Zdravotnické noviny 2002; 51: 22-23.
    15. Smith RA, Duffy SW, Gabe R, Tabar L, Yen AM, Chen TH. The randomized trials of breast cancer screening: what have we learned? Radiol Clin North Am. 2004; 42(5): 793-806. Go to original source... Go to PubMed...
    16. Tabár L, Dean PB. Mammography and breast cancer: the new era. Int J Gynaecol Obstet. 2003; 82(3): 319-326. Go to original source... Go to PubMed...
    17. Tabar L, Dean PB. Thirty years of experience with mammography screening: a new approach to the diagnosis and treatment of breast cancer. Breast Cancer Res. 2008; 10(Suppl 4): 3. Epub 2008 Dec 18. Go to original source... Go to PubMed...
    18. Tabár L, Dean PB. A new era in the diagnosis and treatment of breast cancer. Breast J. 2010; 16(Suppl 1): 2-4. Go to original source... Go to PubMed...
    19. Van Schoor G, Moss SM, Otten JD, Donders R, Paap E, den Heeten GJ, Holland R, Broeders MJ, Verbeek AL. Effective biennial mammographic screening in women aged 40-49. Eur J Cancer. 2010; 46(18): 3137-3140. Epub 2010 Oct 28. Go to original source... Go to PubMed...

    Return to the content


    Oncology

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.